Mustang Bio Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights Nov 12, 2019
Fortress Biotech Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights Nov 12, 2019
Checkpoint Therapeutics Announces Presentation of Anti-PD-L1 Cosibelimab Data at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting Nov 08, 2019
Checkpoint Therapeutics Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights Nov 07, 2019
Mustang Bio Announces MB-107 Lentiviral Gene Therapy and MB-106 CD20-Targeted CAR T Data Selected for Presentations at 61st American Society of Hematology Annual Meeting Nov 06, 2019
Avenue Therapeutics Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights Nov 04, 2019
Avenue Therapeutics Announces Publication of IV Tramadol Phase 1 Clinical Data in Clinical Pharmacology in Drug Development Oct 28, 2019
Mustang Bio Announces Dosing of First Participant in Phase 1 Clinical Trial of MB-108 (Oncolytic Virus C134) to Treat Glioblastoma Oct 24, 2019
